Alcon Research, Ltd.

Novartis Ag

Francisco Javier Galán

Daniel A Gamache

Laman L Alani

Onkar N Singh

Malay Ghosh

Nuria Carreras

Carmen Martinez

Nuria Jiménez

Bhagwati P Kabra

Roman Vidal

Nuria Carreras Perdiguer

Inmaculada Campins

Núria Carreras Perdiguer

Mónica Cuchi

Mridvika

Elena González Puig

Elena Gonzalez Puig

Monica Cuchi

Nuria Jimenez

Carmen Martínez

The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.

High concentration olopatadine ophthalmic composition

The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil.

Pharmaceutical compositions having desirable bioavailability

Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions.

Pharmaceutical compositions containing a fluoroquinolone antibiotic drug

Growing community of inventors

Teia, Spain

Francisco Javier Galán